ArticleFrontiers in endocrinology2026
Anatomical location matters: risk modelling and surgical outcomes in central lymph node metastasis of isthmus PTC.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Isthmus papillary thyroid carcinoma (iPTC) represents a distinct clinical entity with a higher propensity for central lymph node metastasis (CLNM) and greater local aggressiveness compared to lobe-confined PTC. Despite increasing recognition of its unique risk profile, controversy persists regarding optimal surgical management, particularly for small or indolent tumours. Methods: This retrospective cohort study included 319 patients with histologically confirmed iPTC who underwent comprehensive ultrasonographic assessment and thyroid surgery from February 2019 to June 2024 at a high-volume tertiary centre. Lobe-confined PTC cases were matched as controls using propensity score methodology. Clinicopathological features, risk factors for CLNM, surgical outcomes, and recurrence patterns were analysed using univariate and multivariate analyses and ROC/AUC modelling. A predictive nomogram for CLNM was developed and internally validated using 1,000 bootstrap resamples with optimism correction. Results: The iPTC cohort exhibited a significantly higher CLNM burden than matched lobe-confined PTC controls, independent of tumour size or multiplicity. Multivariate analysis identified male sex, increased isthmus tumour diameter, and calcification as independent preoperative predictors of CLNM. The derived nomogram demonstrated acceptable discrimination (optimism-corrected AUC 0.722, 95% CI 0.645-0.802) and internal calibration. Surgical extent (total thyroidectomy versus less extensive resection) was associated with increased perioperative morbidity but did not improve early recurrence rates in selected cases. There were no lymph node or distant recurrences on intermediate-term follow-up. Conclusions: Isthmus location independently increases central nodal metastatic risk in PTC. Risk modelling with simple clinical and ultrasonographic factors quantifies the probability of central lymph node metastasis and highlights the trade-off between more extensive thyroid resection and increased perioperative morbidity. We did not observe an early recurrence or survival advantage associated with more extensive surgery in this cohort, within the limits of intermediate follow-up and routine central dissection; instead, they support individualised, risk-adapted decision-making that requires validation in prospective outcome studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.